IMMUNOMEDICS INC's ticker is and the CUSIP is 452907958. A total of 2 filers reported holding IMMUNOMEDICS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $25,041,000 | +381.0% | 294,500 | +100.5% | 0.08% | +229.2% |
| Q2 2020 | $5,206,000 | +519.0% | 146,900 | +135.4% | 0.02% | +242.9% |
| Q1 2020 | $841,000 | -72.7% | 62,400 | -57.1% | 0.01% | -66.7% |
| Q4 2019 | $3,077,000 | +86.4% | 145,400 | +16.8% | 0.02% | +61.5% |
| Q3 2019 | $1,651,000 | +537.5% | 124,500 | +565.8% | 0.01% | +550.0% |
| Q2 2019 | $259,000 | -70.2% | 18,700 | -58.6% | 0.00% | -80.0% |
| Q1 2019 | $868,000 | -95.4% | 45,200 | -96.6% | 0.01% | -93.9% |
| Q4 2018 | $18,965,000 | -55.5% | 1,329,000 | -35.0% | 0.16% | -51.3% |
| Q3 2018 | $42,595,000 | -15.7% | 2,044,900 | -4.2% | 0.34% | -22.0% |
| Q2 2018 | $50,533,000 | +130.2% | 2,134,900 | +42.1% | 0.43% | +95.5% |
| Q1 2018 | $21,949,000 | +39.7% | 1,502,300 | +54.6% | 0.22% | +100.9% |
| Q4 2017 | $15,706,000 | +162.9% | 971,900 | +127.5% | 0.11% | +103.7% |
| Q3 2017 | $5,974,000 | +66.9% | 427,300 | +5.4% | 0.05% | +45.9% |
| Q2 2017 | $3,579,000 | -21.2% | 405,300 | -42.2% | 0.04% | -30.2% |
| Q1 2017 | $4,541,000 | +186.3% | 701,800 | +62.4% | 0.05% | +253.3% |
| Q4 2016 | $1,586,000 | +14.4% | 432,200 | +1.3% | 0.02% | 0.0% |
| Q3 2016 | $1,386,000 | +1.5% | 426,500 | -27.5% | 0.02% | -6.2% |
| Q2 2016 | $1,366,000 | +77.6% | 588,600 | +91.3% | 0.02% | +45.5% |
| Q1 2016 | $769,000 | -33.9% | 307,700 | -18.9% | 0.01% | -21.4% |
| Q4 2015 | $1,164,000 | +151.9% | 379,300 | +41.2% | 0.01% | +133.3% |
| Q3 2015 | $462,000 | -59.7% | 268,700 | -4.7% | 0.01% | -62.5% |
| Q2 2015 | $1,145,000 | +35.5% | 282,000 | +27.8% | 0.02% | +23.1% |
| Q1 2015 | $845,000 | -51.2% | 220,700 | -38.9% | 0.01% | -50.0% |
| Q4 2014 | $1,733,000 | +50.2% | 361,100 | +16.4% | 0.03% | +44.4% |
| Q3 2014 | $1,154,000 | -13.6% | 310,100 | -15.2% | 0.02% | -14.3% |
| Q2 2014 | $1,335,000 | -46.0% | 365,700 | -37.8% | 0.02% | -50.0% |
| Q1 2014 | $2,473,000 | -31.4% | 587,500 | -25.1% | 0.04% | -22.2% |
| Q4 2013 | $3,607,000 | +50.5% | 784,200 | +102.6% | 0.05% | +17.4% |
| Q3 2013 | $2,396,000 | -14.6% | 387,100 | -25.0% | 0.05% | -33.3% |
| Q2 2013 | $2,806,000 | – | 515,800 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|